Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 1997

View Archived Issues

Andrx seeks patent coverage for new drug delivery system

Patent coverage obtained for SomatoKine in osteoporosis, tissue repair

Positive preclinical results obtained with Avigen's antiparkinsonian gene therapy

Pseudopeptide derivatives of OGP and OGP(10-14) disclosed by Yissum

Pharmacological characterization of CCD-3693, an orally available neuroactive steroid

Thalidomide proves effective in HIV-associated proctitis

Effects of rPAF-AH in opossums with severe pancreatitis

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Insulin therapy found useful in patients with type II diabetes

United Biomedical and California lab to collaborate on novel HIV therapeutic

Preliminary phase III data presented on celecoxib at arthritis symposium

Enbrel phase III and long-term safety data presented at rheumatology meeting

Update on Prizm's novel Directin-based product pipeline

Alza: Q3 1997 highlights

New ACAT inhibitor from Pierre Fabre

GL-701 shows significant steroid-sparing effects in women with active SLE

Synvisc introduced in U.S.

Novartis' NK1 antagonist in clinical studies for pain

Matritech: Q3 1997 highlights

Beclometasone CFC-free MDI for chronic bronchial asthma approved

FDA advisory committee recommends approval of Prandin

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nortran and Bridge Pharma to develop dermal anesthetics

FDA advisory committee to review rotavirus vaccine

Extensive preclinical results described for new NK2 antagonist

HMR and MediGene collaborate on cancer gene therapies

Phase II results with T-cell receptor peptides in RA promising

Phase II begins for psoriasis vaccine

New NK3/NK4 antagonist in the pipeline at SKB

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...